Michael Breckwoldt

Michael Breckwoldt is a Senior Physician and Head of the Section for Immuno-Imaging at the Department of Neuroradiology, Heidelberg University Hospital. He holds an apl. Professorship at Heidelberg University since 2024 and leads an Emmy Noether Independent Research Group since 2021. His work bridges neuroradiology and immuno-oncology, focusing on molecular imaging of brain tumors and neuroinflammatory diseases.

• Education: Studium der Humanmedizin at LMU/TU München (with international stays at Harvard Medical School, NYU, University of Oxford), PhD (summa cum laude, TU München, 2012), Dr. med. (TU München, 2007)
• Key Research Areas: Molecular Imaging, Glioblastoma, Multiple Sclerosis, Neuroinflammation, High-field MRI, Optical Imaging
• Notable Awards: Lucien Appel Award (2019), Marc Dünzl Preis (2016), Gertrud-Reemtsma Promovierendenpreis (2011-2013), Kurt Decker Preis (2008)
• Grants & Funding: Emmy Noether Group Leader (DFG), SFB 1389 Project Leader, Novartis GmbH grants, Else Kröner-Fresenius Stiftung funding

His 10+ recent publications (2018-2025) focus on glioma immunology, vaccine development for brain tumors, neuroinflammatory metabolism, and neuroimaging techniques. These studies frequently appear in Nature, Cell, and Nature Medicine, highlighting his contributions to precision neurooncology and immuno-imaging.